Stay updated with breaking news from Proclaim Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global neurostimulation devices market is experiencing substantial growth, driven by advancements in technology and an increasing prevalence of neurological disorders. The market size is projected to expand from USD 11.1 billion in 2022 to USD 36.5 billion by 2032, growing at a compound annual growth rate (CAGR)...
A Bluetooth connectivity flaw has disabled Abbott implantable pulse generators (IPGs), requiring surgery to remove and replace them.
FDA has issued a Class I recall of 155,028 Abbott Medical implantable neurostimulation systems due to an inability to exit MRI mode, potentially leading to seri
Newark, New Castle, USA, July 04, 2023 (GLOBE NEWSWIRE) -- According to the recent analysis conducted by Growth Plus Reports, the global peripheral nerve...
Abbott has announced the FDA expanded the indication of its BurstDR spinal cord stimulation devices for treating chronic back pain in those who have not had or are ineligible for back surgery.